These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 15077317)

  • 1. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
    Nesher G; Berkun Y; Mates M; Baras M; Rubinow A; Sonnenblick M
    Arthritis Rheum; 2004 Apr; 50(4):1332-7. PubMed ID: 15077317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis.
    Cid MC; Font C; Oristrell J; de la Sierra A; Coll-Vinent B; López-Soto A; Vilaseca J; Urbano-Márquez A; Grau JM
    Arthritis Rheum; 1998 Jan; 41(1):26-32. PubMed ID: 9433866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
    Lee MS; Smith SD; Galor A; Hoffman GS
    Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
    Liozon E; Boutros-Toni F; Ly K; Loustaud-Ratti V; Soria P; Vidal E
    J Rheumatol; 2003 Jun; 30(6):1272-6. PubMed ID: 12784402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
    Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
    Semin Arthritis Rheum; 2008 Oct; 38(2):116-23. PubMed ID: 18221984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
    Berger CT; Wolbers M; Meyer P; Daikeler T; Hess C
    Rheumatology (Oxford); 2009 Mar; 48(3):258-61. PubMed ID: 19129348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Temporal arteritis and cerebrovascular complications].
    Øverlie H; Kerty E
    Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2936-8. PubMed ID: 16276375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.
    Salvarani C; Cimino L; Macchioni P; Consonni D; Cantini F; Bajocchi G; Pipitone N; Catanoso MG; Boiardi L
    Arthritis Rheum; 2005 Apr; 53(2):293-7. PubMed ID: 15818722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy does not seem to benefit giant cell arteritis.
    Narváez J; Bernad B; Nolla JM; Valverde J
    Semin Arthritis Rheum; 2007 Apr; 36(5):322-7. PubMed ID: 17204308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.
    Salvarani C; Casali B; Farnetti E; Pipitone N; Formisano D; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Grazia Catanoso M; Restuccia G; Ghinoi A; Boiardi L
    Arthritis Rheum; 2007 Oct; 56(10):3502-8. PubMed ID: 17907177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis.
    Narváez J; Bernad B; Gómez-Vaquero C; García-Gómez C; Roig-Vilaseca D; Juanola X; Rodriguez-Moreno J; Nolla JM; Valverde J
    Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S57-62. PubMed ID: 18799055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
    Bahlas S; Ramos-Remus C; Davis P
    J Rheumatol; 1998 Jan; 25(1):99-104. PubMed ID: 9458211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aspirin in the treatment of giant cell arteritis.
    Hellmann DB
    Arthritis Rheum; 2004 Apr; 50(4):1026-7. PubMed ID: 15077284
    [No Abstract]   [Full Text] [Related]  

  • 14. [The bane of giant cell arteritis from an ophthalmological viewpoint].
    Meli B; Landau K; Gloor BP
    Schweiz Med Wochenschr; 1996 Oct; 126(43):1821-8. PubMed ID: 9005521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.
    González-Gay MA; Blanco R; Rodríguez-Valverde V; Martínez-Taboada VM; Delgado-Rodriguez M; Figueroa M; Uriarte E
    Arthritis Rheum; 1998 Aug; 41(8):1497-504. PubMed ID: 9704651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients.
    Chevalet P; Barrier JH; Pottier P; Magadur-Joly G; Pottier MA; Hamidou M; Planchon B; El Kouri D; Connan L; Dupond JL; De Wazieres B; Dien G; Duhamel E; Grosbois B; Jego P; Le Strat A; Capdeville J; Letellier P; Agron L
    J Rheumatol; 2000 Jun; 27(6):1484-91. PubMed ID: 10852275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
    Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
    Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis.
    Salvarani C; Della Bella C; Cimino L; Macchioni P; Formisano D; Bajocchi G; Pipitone N; Catanoso MG; Restuccia G; Ghinoi A; Boiardi L
    Rheumatology (Oxford); 2009 Mar; 48(3):250-3. PubMed ID: 19109317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor prognosis of visual outcome after visual loss from giant cell arteritis.
    Danesh-Meyer H; Savino PJ; Gamble GG
    Ophthalmology; 2005 Jun; 112(6):1098-103. PubMed ID: 15885780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.